Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor
Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Leaders in scientific and industrial imaging, Atik Cameras prepares for growth as Dr Panos Kapetanopoulos is promoted to DIrector of Atik Cameras Norwich, UK
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
This strategic collaboration will enable continued innovation in cancer care
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
Subscribe To Our Newsletter & Stay Updated
